About this Journal Submit a Manuscript Table of Contents
Prostate Cancer
Volume 2011 (2011), Article ID 584784, 8 pages
http://dx.doi.org/10.1155/2011/584784
Review Article

Pros and Cons of Focal Therapy for Localised Prostate Cancer

Section of Urology and Andrology, Department of Medical-Surgical Specialties and Public Health, Policlinico Santa Maria della Misericordia Sant'Andrea delle Fratte Perugia, University of Perugia, 06122 Perugia, Italy

Received 11 December 2010; Revised 13 February 2011; Accepted 9 March 2011

Academic Editor: Truls Erik Bjerklund-Johansen

Copyright © 2011 Luigi Mearini and Massimo Porena. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, E. Ward et al., “Cancer statistics, 2008,” CA: Cancer Journal for Clinicians, vol. 58, no. 2, pp. 71–96, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. M. Quinn and P. Babb, “Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons,” BJU International, vol. 90, no. 2, pp. 162–173, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. W. F. Whitmore Jr., “Localised prostatic cancer: management and detection issues,” The Lancet, vol. 343, no. 8908, pp. 1263–1267, 1994. View at Publisher · View at Google Scholar · View at Scopus
  4. C. D. Berg, G. L. Andriole, E. D. Crawford et al., “Mortality results from a randomized prostate-cancer screening trial,” The New England Journal of Medicine, vol. 360, no. 13, pp. 1310–1319, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. F. H. Schröder, J. Hugosson, M. J. Roobol et al., “Screening and prostate-cancer mortality in a randomized european study,” The New England Journal of Medicine, vol. 360, no. 13, pp. 1320–1328, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. I. M. Thompson, D. K. Pauler, P. J. Goodman et al., “Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter,” The New England Journal of Medicine, vol. 350, no. 22, pp. 2239–2321, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. H. B. Carter, A. Kettermann, C. Warlick et al., “Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience,” Journal of Urology, vol. 178, no. 6, pp. 2359–2365, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. L. Klotz, “Active surveillance with selective delayed intervention for favorable risk prostate cancer,” Urologic Oncology, vol. 24, no. 1, pp. 46–50, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. G. Novara, V. Ficarra, C. D'Elia, S. Secco, S. Cavalleri, and W. Artibani, “Prospective evaluation with standardised criteria for postoperative complications after robotic-assisted laparoscopic radical prostatectomy,” European Urology, vol. 57, no. 3, pp. 363–370, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. Y. Pardo, F. Guedea, F. Aguiló et al., “Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment,” Journal of Clinical Oncology, vol. 28, no. 31, pp. 4687–4696, 2010. View at Publisher · View at Google Scholar · View at PubMed
  11. R. J. Santiago, L. Wu, E. Harris et al., “Fifteen-year results of breast-conserving surgery and definitive irradiation for Stage I and II breast carcinoma: the University of Pennsylvania experience,” International Journal of Radiation Oncology Biology Physics, vol. 58, no. 1, pp. 233–240, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. P. T. Scardino and L. L. Abenhaim, “Focal therapy for prostate cancer: analysis by an international panel,” Urology, vol. 72, no. 6, pp. S1–S2, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. E. Xylinas, G. Ploussard, X. Durand et al., “Evaluation of combined oncological and functional outcomes after radical prostatectomy: trifecta rate of achieving continence, potency and cancer control—a literature review,” Urology, vol. 76, no. 5, pp. 1194–1198, 2010. View at Publisher · View at Google Scholar · View at PubMed
  14. B. Djavan, M. Susani, B. Bursa, A. Basharkhah, R. Simak, and M. Marberger, “Predictability and significance of multifocal prostate cancer in the radical prostatectomy specimen,” Techniques in Urology, vol. 5, no. 3, pp. 139–142, 1999. View at Scopus
  15. C. D. Scales, J. C. Presti, C. J. Kane et al., “Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy—results from the SEARCH database,” Journal of Urology, vol. 178, no. 4, pp. 1249–1252, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. V. Mouraviev, J. M. Mayes, J. F. Madden, L. Sun, and T. J. Polascik, “Analysis of laterality and percentage of tumor involvement in 1386 prostatectomized specimens for selection of unilateral focal cryotherapy,” Technology in Cancer Research and Treatment, vol. 6, no. 2, pp. 91–95, 2007. View at Scopus
  17. I. Meiers, D. J. Waters, and D. G. Bostwick, “Preoperative prediction of multifocal prostate cancer and application of focal therapy: review 2007,” Urology, vol. 70, no. 6, pp. S3–S8, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. T. J. Polascik, J. M. Mayes, L. Sun, J. F. Madden, J. W. Moul, and V. Mouraviev, “Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy,” Prostate, vol. 68, no. 13, pp. 1380–1386, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. M. Noguchi, T. A. Stamey, J. E. McNeal, and R. Nolley, “Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers,” Journal of Urology, vol. 170, no. 2 I, pp. 459–463, 2003. View at Scopus
  20. T. A. Stamey, F. S. Freiha, J. E. McNeal, E. A. Redwine, A. S. Whittemore, and H. P. Schmid, “Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer,” Cancer, vol. 71, no. 3, pp. 933–938, 1993. View at Scopus
  21. W. Liu, S. Laitinen, S. Khan et al., “Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer,” Nature Medicine, vol. 15, no. 5, pp. 559–565, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. H. U. Ahmed, “The index lesion and the origin of prostate cancer,” The New England Journal of Medicine, vol. 361, no. 17, pp. 1626–1706, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. G. Onik and W. Barzell, “Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy,” Urologic Oncology, vol. 26, no. 5, pp. 506–510, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. E. D. Crawford, S. S. Wilson, K. C. Torkko et al., “Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy,” BJU International, vol. 96, no. 7, pp. 999–1004, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. T. Furuno, T. Demura, T. Kaneta et al., “Difference of cancer core distribution between first and repeat biopsy: in patients diagnosed by extensive transperineal ultrasound guided template prostate biopsy,” Prostate, vol. 58, no. 1, pp. 76–81, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. J. Kurhanewicz, D. Vigneron, P. Carroll, and F. Coakley, “Multiparametric magnetic resonance imaging in prostate cancer: present and future,” Current Opinion in Urology, vol. 18, no. 1, pp. 71–77, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. J. J. Fütterer, S. W. T. P. J. Heijmink, T. W. J. Scheenen et al., “Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging,” Radiology, vol. 241, no. 2, pp. 449–458, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. N. Girouin, F. Mége-Lechevallier, A. Tonina Senes et al., “Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable?” European Radiology, vol. 17, no. 6, pp. 1498–1509, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. J. S. Yu, J. J. Chung, S. W. Hong, B. H. Chung, J. H. Kim, and K. W. Kim, “Prostate cancer: added value of subtraction dynamic imaging in 3T magnetic resonance imaging with a phased-array body coil,” Yonsei Medical Journal, vol. 49, no. 5, pp. 765–774, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. A. O. Sartor, H. Hricak, T. M. Wheeler et al., “Evaluating localized prostate cancer and identifying candidates for focal therapy,” Urology, vol. 72, no. 6, pp. S12–S24, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. A. Bill-Axelson, L. Holmberg, M. Ruutu et al., “Radical prostatectomy versus watchful waiting in early prostate cancer,” The New England Journal of Medicine, vol. 352, no. 19, pp. 1977–1984, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. M. R. Cooperberg, J. W. Moul, and P. R. Carroll, “The changing face of prostate cancer,” Journal of Clinical Oncology, vol. 23, no. 32, pp. 8146–8151, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. N. J. van As and C. C. Parker, “Active surveillance with selective radical treatment for localized prostate cancer,” Cancer Journal, vol. 13, no. 5, pp. 289–294, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. K. Touijer, “Urinary continence after radical prostatectomy: “beauty is in the eye of the beholder“,” European Urology, vol. 51, no. 4, pp. 879–880, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. M. van Kampen, W. De Weerdt, H. van Poppel, D. De Ridder, H. Feys, and L. Baert, “Effect of pelvic-floor re-education on duration and degree of incontinence after radical prostatectomy: a randomised controlled trial,” The Lancet, vol. 355, no. 9198, pp. 98–102, 2000.
  36. R. M. Bauer, P. J. Bastian, C. Gozzi, and C. G. Stief, “Postprostatectomy Incontinence: all about diagnosis and management,” European Urology, vol. 55, no. 2, pp. 322–333, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. T. M. Koppie and B. Guillonneau, “Predictors of incontinence after radical prostatectomy: where do we stand?” European Urology, vol. 52, no. 1, pp. 22–23, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. M. Noguchi, A. Shimada, O. Nakashima, M. Kojiro, and K. Matsuoka, “Urodynamic evaluation of a suspension technique for rapid recovery of continence after radical retropubic prostatectomy,” International Journal of Urology, vol. 13, no. 4, pp. 373–378, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. J. U. Stolzenburg, E. N. Liatsikos, R. Rabenalt et al., “Nerve sparing endoscopic extraperitoneal radical prostatectomy—effect of puboprostatic ligament preservation on early continence and positive margins,” European Urology, vol. 49, no. 1, pp. 103–111, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. D. F. Penson, D. McLerran, Z. Feng et al., “5-Year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study,” Journal of Urology, vol. 173, no. 5, pp. 1701–1705, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. T. J. Wilt, R. MacDonald, I. Rutks, T. A. Shamliyan, B. C. Taylor, and R. L. Kane, “Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer,” Annals of Internal Medicine, vol. 148, no. 6, pp. 435–448, 2008. View at Scopus
  42. A. Magheli and A. L. Burnett, “Erectile dysfunction following prostatectomy: prevention and treatment,” Nature Reviews Urology, vol. 6, no. 8, pp. 415–427, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. J. P. Mulhall, “Defining and reporting erectile function outcomes after radical prostatectomy: challenges and misconceptions,” Journal of Urology, vol. 181, no. 2, pp. 462–471, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. A. Briganti, U. Capitanio, F. K. H. Chun et al., “Prediction of sexual function after radical prostatectomy,” Cancer, vol. 115, no. 13, pp. 3150–3159, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. D. D. Jeffery, J. P. Tzeng, F. J. Keefe et al., “Initial report of the cancer patient-reported outcomes measurement information system (PROMIS) sexual function committee: review of sexual function measures and domains used in oncology,” Cancer, vol. 115, no. 6, pp. 1142–1153, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. M. W. Brown, J. P. Brooks, P. S. Albert, and M. M. Poggi, “An analysis of erectile function after intensity modulated radiation therapy for localized prostate carcinoma,” Prostate Cancer and Prostatic Diseases, vol. 10, no. 2, pp. 189–193, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. A. Peltier, R. van Velthoven, and T. Roumeguère, “Current management of erectile dysfunction after cancer treatment,” Current Opinion in Oncology, vol. 21, no. 4, pp. 303–309, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. T. Lehrfeld and D. I. Lee, “The role of vacuum erection devices in penile rehabilitation after radical prostatectomy,” International Journal of Impotence Research, vol. 21, no. 3, pp. 158–164, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. K. Hatzimouratidis, A. L. Burnett, D. Hatzichristou, A. R. McCullough, F. Montorsi, and J. P. Mulhall, “Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application,” European Urology, vol. 55, no. 2, pp. 334–347, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. T. K. Johnson, F. D. Gilliland, R. M. Hoffman et al., “Racial/ethnic differences in functional outcomes in the 5 years after diagnosis of localized prostate cancer,” Journal of Clinical Oncology, vol. 22, no. 20, pp. 4193–4201, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. A. Widmark, P. Fransson, and B. Tavelin, “Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population,” Cancer, vol. 74, no. 9, pp. 2520–2532, 1994. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Crook, B. Esche, and N. Futter, “Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective,” Urology, vol. 47, no. 3, pp. 387–394, 1996. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Franklin, C. A. Parker, and K. M. Morton, “Late effects of radiation therapy for prostate carcinoma: the patient's perspective of bladder, bowel and sexual morbidity,” Australasian Radiology, vol. 42, no. 1, pp. 58–65, 1998. View at Scopus
  54. A. L. Potosky, W. W. Davis, R. M. Hoffman et al., “Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study,” Journal of the National Cancer Institute, vol. 96, no. 18, pp. 1358–1367, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. V. E. Arterbery, A. Frazier, P. Dalmia, J. Siefer, M. Lutz, and A. Porter, “Quality of life after permanent prostate implant,” Seminars in Surgical Oncology, vol. 13, no. 6, pp. 461–464, 1997. View at Publisher · View at Google Scholar · View at Scopus
  56. J. A. Talcott, J. A. Clark, P. C. Stark, and S. P. Mitchell, “Long-term treatment related complications of brachytherapy for early prostate cancer: a survey of patients previously treated,” Journal of Urology, vol. 166, no. 2, pp. 494–499, 2001. View at Scopus
  57. T. Krupski, G. R. Petroni, E. A. Bissonette, and D. Theodorescu, “Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer,” Urology, vol. 55, no. 5, pp. 736–742, 2000. View at Scopus
  58. D. C. Miller, M. G. Sanda, R. L. Dunn et al., “Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy,” Journal of Clinical Oncology, vol. 23, no. 12, pp. 2772–2780, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. J. Harden, A. Schafenacker, L. Northouse et al., “Couples' experiences with prostate cancer: focus group research,” Oncology Nursing Forum, vol. 29, no. 4, pp. 701–709, 2002. View at Scopus
  60. C. T. Soloway, M. S. Soloway, S. S. Kim, and B. R. Kava, “Sexual, psychological and dyadic qualities of the prostate cancer ‘couple’,” BJU International, vol. 95, no. 6, pp. 780–785, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. S.-O. Andersson, O. Andrén, J. Lyth et al., “Managing localized prostate cancer by radical prostatectomy or watchful waiting: cost analysis of a randomized trial (SPCG-4),” Scandinavian Journal of Urology and Nephrology, vol. 45, no. 3, pp. 177–183, 2011. View at Publisher · View at Google Scholar · View at PubMed
  62. C. Bolenz, A. Gupta, T. Hotze et al., “Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer,” European Urology, vol. 57, no. 3, pp. 453–458, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. S. Hummel, E. L. Simpson, P. Hemingway, M. D. Stevenson, and A. Rees, “Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation,” Health Technology Assessment, vol. 14, pp. 1–108, 2010.
  64. V. Mouraviev, I. Nosnik, L. Sun et al., “Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience,” Urology, vol. 69, no. 2, pp. 311–314, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. H. U. Ahmed, D. Pendse, R. Illing, C. Allen, J. H. P. van der Meulen, and M. Emberton, “Will focal therapy become a standard of care for men with localized prostate cancer?” Nature Clinical Practice Oncology, vol. 4, no. 11, pp. 632–642, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. S. E. Eggener, P. T. Scardino, P. R. Carroll et al., “Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities,” Journal of Urology, vol. 178, no. 6, pp. 2260–2267, 2007. View at Publisher · View at Google Scholar · View at PubMed
  67. T. J. Polascik, J. M. Mayes, and V. Mouraviev, “Nerve-sparing focal cryoablation of prostate cancer,” Current Opinion in Urology, vol. 19, no. 2, pp. 182–187, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. T. J. Polascik and V. Mouraviev, “Focal therapy for prostate cancer is a reasonable treatment option in properly selected patients,” Urology, vol. 74, no. 4, pp. 726–730, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. A. H. Hou, K. F. Sullivan, and E. D. Crawford, “Targeted focal therapy for prostate cancer: a review,” Current Opinion in Urology, vol. 19, no. 3, pp. 283–289, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. H. U. Ahmed, C. Moore, and M. Emberton, “Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer,” Surgical Oncology, vol. 18, no. 3, pp. 219–232, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. M. E. Chen, D. A. Johnston, K. Tang, R. J. Babaian, and P. Troncoso, “Detailed mapping of prostate carcinoma foci: biopsy strategy implications,” Cancer, vol. 89, no. 8, pp. 1800–1809, 2000. View at Publisher · View at Google Scholar · View at Scopus
  72. A. M. Wise, T. A. Stamey, J. E. McNeal, and J. L. Clayton, “Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens,” Urology, vol. 60, no. 2, pp. 264–269, 2002. View at Publisher · View at Google Scholar · View at Scopus
  73. K. T. Mai, D. C. Landry, H. M. Yazdi, W. A. Stinson, D. G. Perkins, and C. Morash, “Identification of isolated and early prostatic adenocarcinoma in radical prostatectomy specimens with correlation to biopsy corres: clinical and pathogenetic significance,” Pathology Research and Practice, vol. 198, no. 10, pp. 655–663, 2002. View at Scopus
  74. K. R. Rice, B. Furusato, Y. Chen, D. G. McLeod, I. A. Sesterhenn, and S. A. Brassell, “Clinicopathological behavior of single focus prostate adenocarcinoma,” Journal of Urology, vol. 182, no. 6, pp. 2689–2694, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. A. Villers, J. E. McNeal, F. S. Freiha, and T. A. Stamey, “Multiple cancers in the prostate: morphologic features of clinically recognized versus incidental tumors,” Cancer, vol. 70, no. 9, pp. 2313–2318, 1992. View at Publisher · View at Google Scholar · View at Scopus
  76. D. B. Rukstalis, J. L. Goldknopf, E. M. Crowley, and F. U. Garcia, “Prostate cryoablation: a scientific rationale for future modifications,” Urology, vol. 60, no. 2, pp. 19–25, 2002. View at Publisher · View at Google Scholar · View at Scopus
  77. F. Abdollah, V. Scattoni, M. Raber, et al., “The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy,” BJU International. In press. View at Publisher · View at Google Scholar · View at PubMed
  78. B. M. Gburek, T. A. Kollmorgen, J. Qian, S. M. D'Souza-Gburek, M. M. Lieber, and R. B. Jenkins, “Chromosomal anomalies in stage D1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescence in situ hybridization,” Journal of Urology, vol. 157, no. 1, pp. 223–227, 1997. View at Scopus
  79. A. G. Anastasiadis, M. P. Lichy, U. Nagele et al., “MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies,” European Urology, vol. 50, no. 4, pp. 738–749, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  80. E. H. Lambert, K. Bolte, P. Masson, and A. E. Katz, “Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer,” Urology, vol. 69, no. 6, pp. 1117–1120, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  81. G. Onik, D. Vaughan, R. Lotenfoe, M. Dineen, and J. Brady, “The “male lumpectomy”: focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up,” Urologic Oncology, vol. 26, no. 5, pp. 500–505, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  82. D. S. Ellis, T. B. Manny, and J. C. Rewcastle, “Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results,” Urology, vol. 70, no. 6, pp. S9–S15, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  83. M. D. Truesdale, P. J. Cheetham, G. W. Hruby et al., “An evaluation of patient selection criteria on predicting progression-free survival after primary focal unilateral nerve-sparing cryoablation for prostate cancer: recommendations for follow up,” Cancer Journal, vol. 16, no. 5, pp. 544–549, 2010. View at Publisher · View at Google Scholar · View at PubMed
  84. G. Onik, P. Narayan, D. Vaughan, M. Dineen, and R. Brunelle, “Focal “nerve-sparing” cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency,” Urology, vol. 60, no. 1, pp. 109–114, 2002. View at Publisher · View at Google Scholar · View at Scopus
  85. D. K. Bahn, P. Silverman, F. Lee, R. Badalament, E. D. Bahn, and J. C. Rewcastle, “Focal prostate cryoablation: initial results show cancer control and potency preservation,” Journal of Endourology, vol. 20, no. 9, pp. 688–692, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  86. S. Muto, T. Yoshii, K. Saito, Y. Kamiyama, H. Ide, and S. Horie, “Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer,” Japanese Journal of Clinical Oncology, vol. 38, no. 3, pp. 192–199, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  87. M. Atri, M. R. Gertner, M. A. Haider, R. A. Weersink, and J. Trachtenberg, “Contrast-enhanced ultrasonography for real-time monitoring of interstitial laser thermal therapy in the focal treatment of prostate cancer,” Journal of the Canadian Urological Association, vol. 3, no. 2, pp. 125–130, 2009. View at Scopus
  88. O. Raz, M. A. Haider, S. R.H. Davidson et al., “Real-time magnetic resonance imaging-guided focal laser therapy in patients with low-risk prostate cancer,” European Urology, vol. 58, no. 1, pp. 173–177, 2010. View at Publisher · View at Google Scholar · View at PubMed
  89. U. Lindner, R. A. Weersink, M. A. Haider et al., “Image guided photothermal focal therapy for localized prostate cancer: phase I trial,” Journal of Urology, vol. 182, no. 4, pp. 1371–1377, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  90. U. Lindner, N. Lawrentschuk, R. A. Weersink et al., “Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy,” European Urology, vol. 57, no. 6, pp. 1111–1114, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  91. P. Colin, J.-P. Estevez, N. Betrouni et al., “Photodynamic therapy and prostate cancer,” Progres en Urologie, vol. 21, no. 2, pp. 85–92, 2011. View at Publisher · View at Google Scholar · View at PubMed
  92. M. G. Sanda, R. L. Dunn, J. Michalski et al., “Quality of life and satisfaction with outcome among prostate-cancer survivors,” The New England Journal of Medicine, vol. 358, no. 12, pp. 1250–1261, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  93. J. De La Rosette, H. Ahmed, J. Barentsz et al., “Focal therapy in prostate cancer-report from a consensus panel,” Journal of Endourology, vol. 24, no. 5, pp. 775–780, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus